about
Adult pituitary stem cells: from pituitary plasticity to adenoma developmentConcise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous CraniopharyngiomaExpression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas.Expression of the pituitary stem/progenitor marker GFRα2 in human pituitary adenomas and normal pituitary.Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans.The crossroads between cancer stem cells and aging.A hierarchy of endothelial colony-forming cell activity displayed by bovine corneal endothelial cells.Pituitary stem cell update and potential implications for treating hypopituitarismThe cancer stem cell paradigm: a new understanding of tumor development and treatment.Ossifying fibroma tumor stem cells are maintained by epigenetic regulation of a TSP1/TGF-β/SMAD3 autocrine loop.The identification of human pituitary adenoma-initiating cells.Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cellsIdentification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45.Global expression profile of tumor stem-like cells isolated from MMQ rat prolactinoma cell.Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.A paradigm shift is required for the risk assessment of potential human health after exposure to low level chemical exposures: a response to the toxicity testing in the 21st century report.Stem cells and cancer stem-like cells in endocrine tissues.Stem cells in the canine pituitary gland and in pituitary adenomas.Pituitary adenoma with gangliocytic component: report of 5 cases with focus on immunoprofile of gangliocytic component.The cancer stem cell hypothesis: a guide to potential molecular targets.Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor.The role of stem cells in benign tumors.Functional Characteristics of Multipotent Mesenchymal Stromal Cells from Pituitary Adenomas.Analysis of immunoexpression of common cancer stem cell markers in ameloblastoma.Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.Cancer stem cell subsets and their relationshipsIdentification of CD133+ cells in pituitary adenomas.Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.The Stem Cell Connection of Pituitary Tumors.Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.Pituitary adenomas, stem cells, and cancer stem cells: what's new?Characteristics of ganglion cells in pituitary gangliocytomas.Maintenance of Stemlike Glioma Cells and Microglia in an Organotypic Glioma Slice Model.
P2860
Q27024298-B9893A9C-4E11-4C9D-BE2E-25472106BDFFQ28069546-174DE899-DF60-4E28-9D6F-51355EC8CE3DQ33596189-BECFA10D-4202-4126-A74F-90E708ADDB94Q33875721-D6A43316-B766-4F1F-970A-7E605EA9BB46Q34154786-727B69A1-0726-437D-8711-E3705833C42DQ35105262-C7D82925-1815-4BAB-B20C-FD3BE7464F61Q35566484-79F44608-0C5E-4317-89D0-A8143B398D83Q35680149-61E5777C-DD27-4536-9421-30EB571A1576Q36014901-721FC3CE-9A59-44FE-A82A-4D2536BCF9E0Q36854372-F1CC5202-C83F-44FF-B631-7A0951A79A35Q37388119-24031B54-AEF2-406E-BBC3-E84B25C8C344Q37450220-48C77044-55A5-410B-B8B9-1127DC35A3F2Q37481912-FC2C06A6-D1DA-4AE4-BD59-B5183D2A64D5Q37575552-31461ACD-1C4F-4168-A0FF-34102A794BBBQ37615467-DDEFA572-3363-44E8-AD58-E97370A5AE93Q37690499-393D249A-63A2-412A-ACE1-9D4AD2F63A75Q37773116-B71BD8D6-ED32-43A6-A682-93B475668509Q38084129-28A233AB-A59F-430F-A64F-843B505CCE42Q38169776-71A42B14-B9B9-484E-9E06-83576154B014Q38178866-90DA062F-3008-4FB0-BD6D-06FB885AA71FQ38254181-045C64E9-8D02-483B-9624-B8B2E556588AQ38850768-75ACD804-6A97-4D89-B767-819F682BB234Q38961276-23660FCA-1B0C-46D1-BA56-CB08B5B1C5EBQ41959136-F8AC3103-A857-4EE8-B8AB-21B05BC2ACF8Q42017272-9C49B120-569A-4716-B4EA-5A644BB56E56Q42504723-43F7C9CC-16F8-48D3-A83E-D9B4E3966DCDQ42735675-4A08A7CB-E586-4CD3-9B24-E78300407CDAQ46792285-6E7FA593-0894-4F9E-9C50-CEFA44138446Q47117422-E073631F-55A9-4439-801F-A17F8820E8AEQ47122908-E69E81AF-E660-426D-8879-0700295B87E5Q48116589-2026288F-5F4C-4638-BD92-6CAAD2AEC6FAQ49986979-DB56095E-3BBA-4E8F-921E-A8D0554FA688Q51649914-D011BD62-B815-4215-9AA5-B0B5FADBE150Q53366736-3396453B-E88D-4F4C-866E-5F706F90B851
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isolation of tumour stem-like cells from benign tumours
@en
Isolation of tumour stem-like cells from benign tumours.
@nl
type
label
Isolation of tumour stem-like cells from benign tumours
@en
Isolation of tumour stem-like cells from benign tumours.
@nl
prefLabel
Isolation of tumour stem-like cells from benign tumours
@en
Isolation of tumour stem-like cells from benign tumours.
@nl
P2093
P2860
P356
P1476
Isolation of tumour stem-like cells from benign tumours
@en
P2093
D L Farkas
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605142
P407
P577
2009-06-30T00:00:00Z